17β-estradiol upregulates GREB1 and accelerates ovarian tumor progression in vivo

International Journal of Cancer

Volumn 135, Issue 5, 2014, Pages 1072-1084

  Laviolette, Laura A ^a,b   Hodgkinson, Kendra M ^a,b   Minhas, Neha ^b   Perez Iratxeta, Carol ^b   Vanderhyden, Barbara C ^a,b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

estrogen; GREB1; microarray; mouse model; ovarian cancer

Indexed keywords

ESTRADIOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES CELL; CANCER CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GREB1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OVARY TUMOR; PRIORITY JOURNAL; RNA INTERFERENCE; SURVIVAL TIME; TUMOR GENE; TUMOR VOLUME; UPREGULATION;

ESTROGEN; GREB1; MICROARRAY; MOUSE MODEL; OVARIAN CANCER;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; DOWN-REGULATION; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, SCID; NEOPLASM PROTEINS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR BURDEN; UP-REGULATION;

EID: 84902549908     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28741     Document Type: Article

References (48)

1. Siegel R, Ma J, Zou Z, Jemal A,. Cancer statistics, 2014, CA Cancer J Clin 2014; 64: 9-29.
2. Naora H, Montell DJ,. Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer 2005; 5: 355-66.
3. Lacey JV, Jr, Mink PJ, Lubin JH, et al. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 2002; 288: 334-41.
4. Glud E, Kjaer SK, Thomsen BL, et al. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Arch Intern Med 2004; 164: 2253-9.
5. Beral V, Bull D, Green J, et al. Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 2007; 369: 1703-10.
6. Morch LS, Lokkegaard E, Andreasen AH, et al. Hormone therapy and ovarian cancer. JAMA 2009; 302: 298-305.
7. Rossing MA, Cushing-Haugen KL, Wicklund KG, et al. Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 2548-56.
8. Wright JW, Toth-Fejel S, Stouffer RL, et al. Proliferation of rhesus ovarian surface epithelial cells in culture: lack of mitogenic response to steroid or gonadotropic hormones. Endocrinology 2002; 143: 2198-207.
9. Bai W, Oliveros-Saunders B, Wang Q, et al. Estrogen stimulation of ovarian surface epithelial cell proliferation. In Vitro Cell Dev Biol Anim 2000; 36: 657-66.
10. Symonds DA, Merchenthaler I, Flaws JA,. Methoxychlor and estradiol induce oxidative stress DNA damage in the mouse ovarian surface epithelium. Toxicol Sci 2008; 105: 182-7.
11. Laviolette LA, Garson K, Macdonald EA, et al. 17Beta-estradiol accelerates tumor onset and decreases survival in a transgenic mouse model of ovarian cancer. Endocrinology 2010; 151: 929-38.
12. Choi KC, Kang SK, Tai CJ, et al. Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells. Endocrinology 2001; 142: 2351-60.
13. Mabuchi S, Ohmichi M, Kimura A, et al. Estrogen inhibits paclitaxel-induced apoptosis via the phosphorylation of apoptosis signal-regulating kinase 1 in human ovarian cancer cell lines. Endocrinology 2004; 145: 49-58.
14. Armaiz-Pena GN, Mangala LS, Spannuth WA, et al. Estrous cycle modulates ovarian carcinoma growth. Clin Cancer Res 2009; 15: 2971-8.
15. Bardin A, Moll F, Margueron R, et al. Transcriptional and posttranscriptional regulation of fibulin-1 by estrogens leads to differential induction of messenger ribonucleic acid variants in ovarian and breast cancer cells. Endocrinology 2005; 146: 760-8.
16. Gao N, Nester RA, Sarkar MA,. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. Toxicol Appl Pharmacol 2004; 196: 124-35.
17. Ding JX, Feng YJ, Yao LQ, et al. The reinforcement of invasion in epithelial ovarian cancer cells by 17 beta-Estradiol is associated with up-regulation of Snail. Gynecol Oncol 2006; 103: 623-30.
18. Park SH, Cheung LW, Wong AS, et al. Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha. Mol Endocrinol 2008; 22: 2085-98.
19. Ghosh MG, Thompson DA, Weigel RJ,. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res 2000; 60: 6367-75.
20. Rae JM, Johnson MD, Scheys JO, et al. GREB 1 is a critical regulator of hormone dependent breast cancer growth. Breast Cancer Res Treat 2005; 92: 141-9.
21. Mohammed H, D'Santos C, Serandour AA, et al. Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. Cell Rep 2013; 3: 342-9.
22. Clark-Knowles KV, Garson K, Jonkers J, et al. Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes. Exp Cell Res 2007; 313: 133-45.
23. Gamwell LF, Collins O, Vanderhyden BC,. The mouse ovarian surface epithelium contains a population of LY6A (SCA-1) expressing progenitor cells that are regulated by ovulation-associated factors. Biol Reprod 2012; 87: 80.
24. Huber W, von Heydebreck A, Sultmann H, et al. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 2002; 18 (Suppl 1): S96-S104.
25. Irizarry RA, Bolstad BM, Collin F, et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003; 31: e15.
26. Smyth GK,. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3:Article3.
27. Sayers EW, Barrett T, Benson DA, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2010; 38: D5-D16.
28. Kanehisa M, Goto S, Furumichi M, et al. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010; 38: D355-D360.
29. Murdoch WJ, Van Kirk EA,. Steroid hormonal regulation of proliferative, p53 tumor suppressor, and apoptotic responses of sheep ovarian surface epithelial cells. Mol Cell Endocrinol 2002; 186: 61-7.
30. Rae JM, Johnson MD, Cordero KE, et al. GREB1 is a novel androgen-regulated gene required for prostate cancer growth. Prostate 2006; 66: 886-94.
31. Deschenes J, Bourdeau V, White JH, et al. Regulation of GREB1 transcription by estrogen receptor alpha through a multipartite enhancer spread over 20 kb of upstream flanking sequences. J Biol Chem 2007; 282: 17335-9.
32. Sun J, Nawaz Z, Slingerland JM,. Long-range activation of GREB1 by estrogen receptor via three distal consensus estrogen-responsive elements in breast cancer cells. Mol Endocrinol 2007; 21: 2651-62.
33. Raulic S, Ramos-Valdes Y, DiMattia GE,. Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro. J Endocrinol 2008; 197: 517-29.
34. Charpentier AH, Bednarek AK, Daniel RL, et al. Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res 2000; 60: 5977-83.
35. Bouras T, Southey MC, Chang AC, et al. Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res 2002; 62: 1289-95.
36. Graham JD, Roman SD, McGowan E, et al. Preferential stimulation of human progesterone receptor B expression by estrogen in T-47D human breast cancer cells. J Biol Chem 1995; 270: 30693-700.
37. Kocanova S, Kerr EA, Rafique S, et al. Activation of estrogen-responsive genes does not require their nuclear co-localization. PLoS Genet 2010; 6: e1000922.
38. Allan CM, Couse JF, Simanainen U, et al. Estradiol induction of spermatogenesis is mediated via an estrogen receptor-{alpha} mechanism involving neuroendocrine activation of follicle-stimulating hormone secretion. Endocrinology 2010; 151: 2800-10.
39. Honda S, Kashiwagi M, Ookata K, et al. Regulation by 1alpha,25- dihydroxyvitamin D(3) of expression of stanniocalcin messages in the rat kidney and ovary. FEBS Lett 1999; 459: 119-22.
40. Luo CW, Pisarska MD, Hsueh AJ,. Identification of a stanniocalcin paralog, stanniocalcin-2, in fish and the paracrine actions of stanniocalcin-2 in the mammalian ovary. Endocrinology 2005; 146: 469-76.
41. Janne O, Kauppila A, Syrjala P, et al. Comparison of cytosol estrogen and progestin receptor status in malignant and benign tumors and tumor-like lesions of human ovary. Int J Cancer 1980; 25: 175-9.
42. Galli MC, De Giovanni C, Nicoletti G, et al. The occurrence of multiple steroid hormone receptors in disease-free and neoplastic human ovary. Cancer 1981; 47: 1297-302.
43. Willcocks D, Toppila M, Hudson CN, et al. Estrogen and progesterone receptors in human ovarian tumors. Gynecol Oncol 1983; 16: 246-53.
44. Jones LA, Edwards CL, Freedman RS, et al. Estrogen and progesterone receptor titers in primary epithelial ovarian carcinomas. Int J Cancer 1983; 32: 567-71.
45. Miller WL,. Molecular biology of steroid hormone synthesis. Endocr Rev 1988; 9: 295-318.
46. Shi Z, Zhang H, Ding L, et al. The effect of perfluorododecanonic acid on endocrine status, sex hormones and expression of steroidogenic genes in pubertal female rats. Reprod Toxicol 2009; 27: 352-9.
47. Syed V, Zhang X, Lau KM, et al. Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells. Oncogene 2005; 24: 8128-43.
48. Walker G, MacLeod K, Williams AR, et al. Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer. Gynecol Oncol 2007; 106: 461-8.